Drug class
Ophthalmic Steroids
Ophthalmic steroids are a class of synthetic corticosteroid medications formulated for topical, periocular, or intraocular administration to manage ocular inflammation and immune-mediated conditions. Read more about Ophthalmic Steroids
110 drugs in this class 45 manufacturers
Drugs in Ophthalmic Steroids
TOBRAMYCIN-DEXAMETHASONE (tobramycin/dexamethasone)
DIFLUPREDNATE
NEOMYCIN-POLYMYXIN-DEXAMETH (neomycin/polymyxin B sulfate/dexamethasone)
LOTEPREDNOL ETABONATE
NEOMYCIN-POLYMYXIN-DEXAMETH (neomycin/polymyxin B sulfate/dexamethasone)
TOBRAMYCIN-DEXAMETHASONE (tobramycin/dexamethasone)
DIFLUPREDNATE
NEOMYCIN-BACITRACIN-POLY-HC (neomycin sulfate/bacitracin zinc/polymyxin B/hydrocortisone)
Ophthalmic steroids are a class of synthetic corticosteroid medications formulated for topical, periocular, or intraocular administration to manage ocular inflammation and immune-mediated conditions.
They primarily function by inducing lipocortins to inhibit phospholipase A2, thereby suppressing the release of arachidonic acid and the subsequent biosynthesis of inflammatory prostaglandins and leukotrienes while decreasing vascular permeability, cellular infiltration, and tissue edema.
Clinically, these agents are utilized across anterior- and posterior-segment disorders, including uveitis, severe allergic or inflammatory conjunctivitis, keratitis, post-surgical inflammation, and retinal pathologies such as macular edema.
-
nih.gov
Ophthalmic steroids are a class of synthetic corticosteroid medications formulated for topical, periocular, or intraocular administration to manage ocular inflammation and immune-mediated conditions Clinically, these agents are utilized across anterior- and posterior-segment disorders, including uveitis, severe allergic or inflammatory conjunctivitis, keratitis, post-surgical inflammation, and retinal pathologies such as macular edema
-
nv.gov
Ophthalmic steroids are a class of synthetic corticosteroid medications formulated for topical, periocular, or intraocular administration to manage ocular inflammation and immune-mediated conditions They primarily function by inducing lipocortins to inhibit phospholipase A2, thereby suppressing the release of arachidonic acid and the subsequent biosynthesis of inflammatory prostaglandins and leukotrienes while decreasing vascular permeability, cellular infiltration, and tissue edema Clinically, ...
-
fda.gov
They primarily function by inducing lipocortins to inhibit phospholipase A2, thereby suppressing the release of arachidonic acid and the subsequent biosynthesis of inflammatory prostaglandins and leukotrienes while decreasing vascular permeability, cellular infiltration, and tissue edema Clinically, these agents are utilized across anterior- and posterior-segment disorders, including uveitis, severe allergic or inflammatory conjunctivitis, keratitis, post-surgical inflammation, and retinal patho...
-
fda.gov
Clinically, these agents are utilized across anterior- and posterior-segment disorders, including uveitis, severe allergic or inflammatory conjunctivitis, keratitis, post-surgical inflammation, and retinal pathologies such as macular edema
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.